Posted by shellson2 on 23rd of Jul 2024 at 10:24 am
NOTE: PACB is worth 500 million now. Reached $34 in 4/2021.
Do not know if any splits occurred....
PRESS RELEASE
Illumina and Pacific Biosciences Announce Termination of Merger
Agreement
SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)-- Illumina,
Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc.
(NASDAQ:PACB) today announced that they have mutually agreed to
terminate their merger agreement, previously announced on
November 1, 2018, under which Illumina would
acquire Pacific Biosciences at a fully diluted enterprise value of
approximately $1.2 billion in an all-cash transaction.
Posted by shellson2 on 23rd of Jul 2024 at 09:50 am
MENLO PARK, Calif., July 23, 2024 (GLOBE NEWSWIRE)
--
PacBio(NASDAQ:
PACB), a
leading developer of high-quality, highly accurate sequencing
solutions, today announced that Novogene is using its Revio
long-read sequencing system to expand the capabilities of its new
lab in Munich, Germany, serving customers across the European
scientific community. Novogene is a leading provider of genomic
services and bioinformatics expertise, working with a wide range of
leading research institutions, clinical and commercial
organizations. The increased accuracy and throughput offered by the
Revio are designed to enable Novogene's customers to scale in-depth
genomic research across rare diseases, cancer, microbes, and
agriculture in a cost-effective way.
"Bringing Revio to our German lab creates new opportunities for
our customers to advance their groundbreaking research. We expect
particularly high demand for the Revio from customers in the rare
disease and cancer spaces, due to the sequencer's ability to
uncover complex repetitive regions, structural variants, and novel
isoforms that are typically missed by short-read and exome
methods," comments Tingting Zhou, Vice President of Novogene. "The
high fidelity of the Revio, combined with PacBio's various kits and
data analysis capabilities, make it an ideal solution to provide
our customers with long-read data in an economical way. We plan to
integrate even more automation into the Revio's workflows to
further increase efficiency and make long-reads accessible to a
wider range of our customers."
The community is delayed by three days for non registered users.
LPSN up another 8%..no news.
LPSN--I got in a week ago, moving up. Anyone follow/have ...
Posted by shellson2 on 23rd of Jul 2024 at 11:04 am
LPSN up another 8%..no news. reports on 7/31
More volume would be welcomed...
PACB bouncing off that trendline backtest
Posted by shellson2 on 23rd of Jul 2024 at 10:37 am
More volume would be welcomed...
yepper
PACB bouncing off that trendline backtest
Posted by shellson2 on 23rd of Jul 2024 at 10:36 am
yepper
NOTE: PACB is worth 500
PACB bouncing off that trendline backtest
Posted by shellson2 on 23rd of Jul 2024 at 10:24 am
NOTE: PACB is worth 500 million now. Reached $34 in 4/2021. Do not know if any splits occurred....
PRESS RELEASE
Illumina and Pacific Biosciences Announce Termination of Merger Agreement
SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger agreement, previously announced on November 1, 2018, under which Illumina would acquire Pacific Biosciences at a fully diluted enterprise value of approximately $1.2 billion in an all-cash transaction.
MENLO PARK, Calif., July 23,
PACB bouncing off that trendline backtest
Posted by shellson2 on 23rd of Jul 2024 at 09:50 am
MENLO PARK, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- PacBio(NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that Novogene is using its Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany, serving customers across the European scientific community. Novogene is a leading provider of genomic services and bioinformatics expertise, working with a wide range of leading research institutions, clinical and commercial organizations. The increased accuracy and throughput offered by the Revio are designed to enable Novogene's customers to scale in-depth genomic research across rare diseases, cancer, microbes, and agriculture in a cost-effective way.
"Bringing Revio to our German lab creates new opportunities for our customers to advance their groundbreaking research. We expect particularly high demand for the Revio from customers in the rare disease and cancer spaces, due to the sequencer's ability to uncover complex repetitive regions, structural variants, and novel isoforms that are typically missed by short-read and exome methods," comments Tingting Zhou, Vice President of Novogene. "The high fidelity of the Revio, combined with PacBio's various kits and data analysis capabilities, make it an ideal solution to provide our customers with long-read data in an economical way. We plan to integrate even more automation into the Revio's workflows to further increase efficiency and make long-reads accessible to a wider range of our customers."
globenewswire.com
Just a moment...
LPSN--I got in a week
Posted by shellson2 on 22nd of Jul 2024 at 11:36 am
LPSN--I got in a week ago, moving up. Anyone follow/have insights?
NNE, SMR--still in woodshed
Posted by shellson2 on 22nd of Jul 2024 at 10:18 am
NNE, SMR--still in woodshed
Accelerating
BTC has recovered since JB news. $1200 swing
Posted by shellson2 on 21st of Jul 2024 at 04:27 pm
Accelerating
BTC has recovered since JB
Posted by shellson2 on 21st of Jul 2024 at 03:43 pm
BTC has recovered since JB news. $1200 swing
Strong volume to boot
QD setup last night that looked like it could follow through on momo
Posted by shellson2 on 18th of Jul 2024 at 12:45 pm
Strong volume to boot
BPGDM AT 89%
Posted by shellson2 on 18th of Jul 2024 at 11:21 am
BPGDM AT 89%
Palantir @52 week hi
Posted by shellson2 on 18th of Jul 2024 at 10:25 am
Palantir @52 week hi
China getting some $ rotation.
Posted by shellson2 on 18th of Jul 2024 at 10:15 am
China getting some $ rotation. I'm in VIPS
At resistance, 1.22
CAN—small crypto play showing good volume today. Up a little.
Posted by shellson2 on 17th of Jul 2024 at 03:55 pm
At resistance, 1.22
CAN—small crypto play showing good
Posted by shellson2 on 17th of Jul 2024 at 03:50 pm
CAN—small crypto play showing good volume today. Up a little.
MDGL--up nicely
Posted by shellson2 on 17th of Jul 2024 at 10:00 am
MDGL--up nicely
Popped AH too
FIP Updated
Posted by shellson2 on 16th of Jul 2024 at 07:18 pm
Popped AH too
Also guys, look at Bloom
FIP Updated
Posted by shellson2 on 16th of Jul 2024 at 07:17 pm
Also guys, look at Bloom (BE). An old high flyer that is again in momo.
These are plays in the electric grid space (A.I. halo)
My favorite play now is
Cryptomania
Posted by shellson2 on 16th of Jul 2024 at 12:57 pm
My favorite play now is CORZ. Miner & Energy play. Their profitability should accelerate at a better clip than some others.
RKT--nearing 52 week hi
Posted by shellson2 on 16th of Jul 2024 at 11:28 am
RKT--nearing 52 week hi